The Board of the Swiss Federal Institutes of Technology has announced the appointment of professors at EPFL. Prof. Li Tang is appointed as Associate Professor of Bioengineering in the School of Engineering (STI).
— EPFL spin-off Leman Biotech has developed a protein that can improve the effectiveness of immunotherapy drugs used to treat some types of cancer. The firm has just completed its first funding round, in the amount of $11 million.
— Congratulations to Tom Enbar, who won the EPFLglobaLeaders doctoral fellowship! This fellowship is funded by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant.
— Yugang and Yuqing’s research paper entitled “Metabolic Reprogramming of Terminally Exhausted CD8+ T cells by IL-10 Enhances Anti-Tumor Immunity” is published in Nature Immunology as a cover story in issue 22 and highlighted in EPFL news, RTS, ACIR, and Nature Middle East. Congratulations!
— Kewen’s research paper entitled “T cell force-responsive delivery of anticancer drugs using mesoporous silica microparticles” is published in Materials Horizons as a cover story in issue 12 and highlighted in EPFL news. Professor Li Tang is also awarded as the Materials Horizons Emerging Investigator. Congratulations!
— Lixia and Yu’s research paper entitled “ Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine” is published in ACS central science and highlighted in EPFL news. Congratulations!
— Yu and Yugang’s review paper entitled “Engineering cancer vaccines using stimuli-responsive biomaterials” is accepted in Nano Research. Congratulations!
Publication and media report
— Our paper about a smart nanogel backpack for enhanced T-cell immunotherapy is published in Nature Biotechnology and highlighted as a cover story of the August issue. Thank all the co-authors, editor and reviewers!
—The paper has been highlighted in many media reports: MIT News, EPFL News, EurekAlert!, Phys.org, Nanowerk, My Science, eCancer, Health Canal, Medindia, Madrid, UPI.com, Science and Enterprise, Brinkwire, Sina, BioArt.
— We are awarded 2018 ERC starting grant (a 5-year grant) to explore a new area for physically modulating immune response for enhanced and safer cancer immunotherapy. Many thanks to ERC for the outstanding support!
— Dr. Tang gave an invited talk at the Symposium SM02—Immune Modulatory Materials—From Design to Translational Applications, 2018 MRS Spring Meeting, Phoenix, Arizona, USA. Thank Susan Thomas and Evan Scott for the opportunity!
— Dr. Tang gave an invited seminar on the Dendritic Cells Immunotherapy Day at Miltenyi Biotec GmbH, Bergisch Gladbach, Germany. See the video here. Thanks to Dr. Andrzej Dzionek and other organizers for the invitation and the fantastic visit!
— Dr. Tang gave an invited talk at the Annual meeting of the PhD program in Pharmaceutical Sciences, The Geneva-Lausanne School of Pharmacy (EPGL), Zermatt, Switzerland. Thanks to the organizers, Dr. Carole Bourquin and Dr. Patrycja Nowak-Sliwinska for the opportunity!
— Dr. Darrell Irvine from MIT visited our lab!
— Dr. Tang gave an invited talk at Department of Materials Science & Engineering at Beijing University of Chemical Technology, Beijing, China. Thanks to Dr. Nana Zhao, and Dr. Fujian Xu for the invitation and the fantastic visit!
— Dr. Tang gave an invited talk at Institute of Functional Nano & Soft Materials at Soochow University, Suzhou, China. Thanks to Dr. Lichen Yin for the invitation and the fantastic visit!
— Dr. Tang gave an invited seminar at ETH Zürich. Thanks to Dr. Marcy Zenobi-Wong, and Dr. Martin Ehrbar, for the invitation and the fantastic visit!
— Dr. Tang delivered a presentation in the Department of Biochemistry and Molecular Medicine at University of California, Davis, Sacramento, CA, USA. Thanks to Dr. Kit Lam and Dr. Yuanpei Li for the invitation!
— Dr. Tang delivered a presentation in the Department of Bioengineering at Stanford University, Stanford, CA, USA. Thanks to Dr. Bo Wang for the invitation!
— Dr. Tang gave an invited talk at the symposium entitled “Biomaterials for Immunotherapy” during the 253rd American Chemical Society (ACS) National Meeting & Exposition, San Francisco, CA, USA. Dr. Tang also chaired a session on immunoengineering. Thanks to the organizers, Dr. Hao Cheng, Dr. Zhen Gu, and Dr. Darrell Irvine, for the opportunity!
— Our laboratory was awarded a project grant from Novartis Foundation for medical-biological Research to target LIGHT to tumor for enhanced cancer immunotherapy. This is a collaborative project with Dr. Yang-Xin Fu’s team at The University of Texas Southwestern Medical Center. Many thanks to Novartis Foundation for the support!
— Our laboratory was awarded a 3-year grant from Fondation Pierre Mercier pour la science to design an innovative cancer vaccine for enhanced lymph node targeting and cross-presentation. Many thanks to the Fondation Pierre Mercier for the generous support!
— Our laboratory was awarded a 4-year, CHF 715’444, project funding from Swiss National Science Foundation (SNSF) to support our research in immunoengineering through responsive nanoparticle drug delivery. Many thanks to SNSF for the ourstanding support!
— Yuqing produced the 1st piece of data in our lab! Congratulations!
— Our laboratory was awarded a EPFL-Biltema-ISREC grant to support our research in enhancing cancer immunotherapy using biomaterials. This is a collaborative project with Dr. Coukos George’s team at Ludwig Institute for Cancer Research, Lausanne. Many thanks to Biltema and ISREC Foundations for the support!
— Dr. Kazunori Kataoka, Dr. Tatsuro Irimura, Dr. Kanjiro Miyata, Dr. Horacio Cabral and Hori from University of Tokyo visited our lab! They are our first visitors!
Opening of our lab
— The Tang laboratory (Laboratory of Biomaterials for Immunoengineering (LBI)) opened!